Data as of 4:05pm ET
| +4.38 / +1.71%|
The 18 analysts offering 12-month price forecasts for Actavis have a median target of 305.00, with a high estimate of 350.00 and a low estimate of 268.00. The median estimate represents a +16.90% increase from the last price of 260.90.
The current consensus among 24 polled investment analysts is to Buy stock in Actavis. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.